Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.91 beats by $0.01. Revenue of $108M (+113% Y/Y) beats...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor
Jazz Pharmaceuticals (JAZZ): Q1 EPS of $0.91 beats by $0.01. Revenue of $108M (+113% Y/Y) beats by $5.5M. (PR)